Chemical biologists design an early 'proof-of-concept' vaccine that could lead to the first effective treatment of xylazine overdose in people.
Read more https://www.sciencedaily.com/releases/2024/04/240403171031.htm
Chemical biologists design an early 'proof-of-concept' vaccine that could lead to the first effective treatment of xylazine overdose in people.
Read more https://www.sciencedaily.com/releases/2024/04/240403171031.htm